Active substance | Sparsentan |
Holder | Bionical Emas T/A Bionical Limited (on behalf of Vifor (International)AG) |
Status | Running |
Indication | Treatment in adults with primary immunoglobulin A nephropathy (IgAN) with a urine protein excretion >1g/day |
Public documents | Approbation |
Information for the patient | |
Informed consent | |
Last update | 19/10/2023 |